 |
인쇄하기
취소
|
AZK teams with Daewoong over Nexium
Industry watchers expect the domestic anti-ulcerant market is about to heat up, as AstraZeneca Korea (AZK) has joined hands with Daewoong Pharm to market Nexium (esomeprazole magnesium).
Esomeprazole is a proton pump inhibitor developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease, gastroensophageal reflux diasease and Zollinger-Ellison syndro...
Esomeprazole is a proton pump inhibitor developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease, gastroensophageal reflux diasease and Zollinger-Ellison syndro...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.